Aceso Life Science Group Limited (HKG:0474)
Hong Kong
· Delayed Price · Currency is HKD 0.119
-0.001 (-0.83%)
Mar 10, 2026, 3:48 PM HKT
Aceso Life Science Group Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 162 | 132 | 350 | 187 | 195 | 198 | Upgrade
|
| Long-Term Investments | 154 | 1,093 | 1,245 | 1,933 | 1,829 | 1,921 | Upgrade
|
| Trading Asset Securities | 143 | 80 | 119 | 415 | 522 | 588 | Upgrade
|
| Loans & Lease Receivables | 27 | 87 | 549 | 654 | 824 | 681 | Upgrade
|
| Other Receivables | 95 | 198 | 213 | 132 | 259 | 167 | Upgrade
|
| Property, Plant & Equipment | 21 | 191 | 253 | 281 | 283 | 291 | Upgrade
|
| Other Intangible Assets | - | 4 | 171 | 171 | 158 | 156 | Upgrade
|
| Other Current Assets | 25 | 32 | 32 | 597 | 110 | 26 | Upgrade
|
| Long-Term Deferred Tax Assets | 7 | 7 | 58 | 54 | 53 | 69 | Upgrade
|
| Other Long-Term Assets | 1,087 | 1,417 | 1,794 | 1,875 | 1,656 | 1,610 | Upgrade
|
| Total Assets | 1,722 | 3,243 | 4,786 | 6,301 | 6,263 | 6,165 | Upgrade
|
| Accounts Payable | 1 | 4 | 6 | 13 | 6 | 4 | Upgrade
|
| Accrued Expenses | - | 91 | 57 | 62 | 108 | 105 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 113 | Upgrade
|
| Current Portion of Long-Term Debt | 102 | 1,714 | 2,053 | 2,137 | 2,124 | 783 | Upgrade
|
| Current Portion of Leases | 3 | 11 | 10 | 14 | 12 | 11 | Upgrade
|
| Long-Term Debt | 1,120 | 561 | 666 | 756 | 857 | 1,947 | Upgrade
|
| Long-Term Leases | 3 | 15 | 9 | 15 | 17 | 18 | Upgrade
|
| Current Income Taxes Payable | 18 | 19 | 16 | 25 | 20 | 21 | Upgrade
|
| Other Current Liabilities | 105 | 66 | 70 | 600 | 179 | 56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 17 | 84 | 100 | 111 | 90 | Upgrade
|
| Total Liabilities | 1,352 | 2,499 | 2,973 | 3,726 | 3,436 | 3,151 | Upgrade
|
| Common Stock | 73 | 73 | 73 | 73 | 74 | 69 | Upgrade
|
| Additional Paid-In Capital | 4,811 | 4,811 | 4,811 | 4,811 | 4,811 | 4,727 | Upgrade
|
| Retained Earnings | -4,144 | -4,338 | -3,443 | -2,981 | -2,717 | -2,355 | Upgrade
|
| Comprehensive Income & Other | -369 | -508 | -507 | -341 | -161 | -59 | Upgrade
|
| Total Common Equity | 371 | 12 | 921 | 1,549 | 2,002 | 2,382 | Upgrade
|
| Minority Interest | -1 | 732 | 892 | 1,026 | 825 | 632 | Upgrade
|
| Shareholders' Equity | 370 | 744 | 1,813 | 2,575 | 2,827 | 3,014 | Upgrade
|
| Total Liabilities & Equity | 1,722 | 3,243 | 4,786 | 6,301 | 6,263 | 6,165 | Upgrade
|
| Total Debt | 1,228 | 2,301 | 2,738 | 2,922 | 3,010 | 2,872 | Upgrade
|
| Net Cash (Debt) | -923 | -2,089 | -2,269 | -2,320 | -2,293 | -2,086 | Upgrade
|
| Net Cash Per Share | -0.13 | -0.29 | -0.31 | -0.32 | -0.31 | -0.30 | Upgrade
|
| Filing Date Shares Outstanding | 7,382 | 7,382 | 7,382 | 7,382 | 7,387 | 6,932 | Upgrade
|
| Total Common Shares Outstanding | 7,382 | 7,382 | 7,382 | 7,382 | 7,387 | 6,932 | Upgrade
|
| Working Capital | 224 | -1,375 | -949 | -868 | -167 | 1,022 | Upgrade
|
| Book Value Per Share | 0.05 | 0.00 | 0.12 | 0.21 | 0.27 | 0.34 | Upgrade
|
| Tangible Book Value | 371 | 8 | 750 | 1,378 | 1,844 | 2,226 | Upgrade
|
| Tangible Book Value Per Share | 0.05 | 0.00 | 0.10 | 0.19 | 0.25 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Financial Services template. Financial Sources.